Overview:
Galileo Research is an Italian biotech company with a pipeline very focused on projects in the oncology and central nervous system (TALL-104, cell therapy), founded on a solid intellectual property base and with national and international partnerships of absolute value. Galileo was born from the research experience of Abiogen Pharma, and is authorized to carry out studies in GLP. Galileo carries out research and development services for the various stages of drug discovery and lead optimization (ADME studies, proteomics, epigenetics, toxicogenomics, pharmacokinetics, bioanalytics), as well as tests for the development of products in the nutraceutical, chemical and cosmetic sectors.